肺功能,功能能力,呼吸和运动肌肉强度在严重至危急的COVID-19后:一项长期研究
Thanunya Ngamsutham1, Warawut Chaiwong1, Sauwaluk Dacha2
1Division of Pulmonary, Critical Care, and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Tuberculosis and respiratory diseases
|August 14, 2024
概括
严重的COVID-19幸存者长期表现出肺功能受损和肌肉力量受损. 呼吸和运动肌肉的恢复在感染后三到六个月内观察到.
科学领域:
- 肺部病理学 肺部病理学
- 康复医学 康复医学 康复医学
- 传染性疾病 传染性疾病
背景情况:
- 已知COVID-19肺炎对肺功能和运动能力的长期影响.
- 在严重/危急的COVID-19幸存者中,关于呼吸和运动肌肉强度的数据有限.
研究的目的:
- 为了检查长期的肺功能.
- 为了评估功能能力.
- 评估严重至危急的COVID-19幸存者的呼吸和运动肌肉力量.
主要方法:
- 对22名COVID-19后肺炎患者和健康成年人的前性观察研究.
- 在出院后的1,3个月和6个月评估肺功能,功能能力和肌肉力量.
- 将COVID-19幸存者和健康的对照组之间的结果进行比较.
主要成果:
- 与对照组相比,COVID-19幸存者的FEV1,FVC,MIP,手握强度,6MWD和5TSTS显著降低.
- %MVV和运动肌肉强度在各组之间没有显著差异.
- 在COVID-19患者的退院后3个月内,FEV1,FVC,MVV,5TSTS和运动能力的显著改善.
结论:
- 肺功能,功能能力和肌肉力量在COVID-19幸存者中受损.
- 呼吸和运动肌肉的恢复发生在COVID-19后3-6个月之间.
- 强调需要评估COVID-19的长期后果.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Acute Respiratory Failure-II
187
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
187
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Acute Respiratory Failure-III
166
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
166
COPD: Pathogenesis and Clinical Features
246
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
246
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


